CLS Stock Overview
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Clicks Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R286.75 |
52 Week High | R328.05 |
52 Week Low | R232.63 |
Beta | 0.17 |
1 Month Change | -2.83% |
3 Month Change | -3.70% |
1 Year Change | 7.77% |
3 Year Change | 15.09% |
5 Year Change | 46.56% |
Change since IPO | 7,348.05% |
Recent News & Updates
Recent updates
Shareholder Returns
CLS | ZA Consumer Retailing | ZA Market | |
---|---|---|---|
7D | 3.1% | 3.5% | 1.1% |
1Y | 7.8% | 0.7% | -4.9% |
Return vs Industry: CLS exceeded the ZA Consumer Retailing industry which returned -1.4% over the past year.
Return vs Market: CLS exceeded the ZA Market which returned -4.6% over the past year.
Price Volatility
CLS volatility | |
---|---|
CLS Average Weekly Movement | 2.6% |
Consumer Retailing Industry Average Movement | 3.5% |
Market Average Movement | 5.0% |
10% most volatile stocks in ZA Market | 11.7% |
10% least volatile stocks in ZA Market | 2.9% |
Stable Share Price: CLS has not had significant price volatility in the past 3 months.
Volatility Over Time: CLS's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | 17,865 | Bertina Engelbrecht | www.clicksgroup.co.za |
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. It operates through two segments: Retail and Distribution. The company retails pharmacy, health, and beauty through stores, and in-store pharmacies for the middle to upper income markets under the Clicks brand name.
Clicks Group Limited Fundamentals Summary
CLS fundamental statistics | |
---|---|
Market cap | R68.90b |
Earnings (TTM) | R2.54b |
Revenue (TTM) | R41.62b |
27.2x
P/E Ratio1.7x
P/S RatioIs CLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLS income statement (TTM) | |
---|---|
Revenue | R41.62b |
Cost of Revenue | R32.31b |
Gross Profit | R9.31b |
Other Expenses | R6.78b |
Earnings | R2.54b |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 10.56 |
Gross Margin | 22.38% |
Net Profit Margin | 6.10% |
Debt/Equity Ratio | 0% |
How did CLS perform over the long term?
See historical performance and comparison